NEO
Neogenomics
Stock NASDAQ – Stock Market Prices, News & Analysis
Neogenomics Inc focuses on providing genetic oncology research services, including molecular and cytogenetic testing for the diagnosis and treatment of cancer.
Neogenomics
NEO
Neogenomics Inc focuses on providing genetic oncology research services, including molecular and cytogenetic testing for the diagnosis and treatment of cancer.
Price history of Neogenomics
Price history of Neogenomics
Performance & Momentum
Strategic Analysis
Neogenomics • 2026
Neogenomics Inc positions itself as a specialized player in molecular and genetic diagnostics services in oncology, addressing a market that is growing steadily. Its model is based on expertise in advanced testing to guide personalized cancer treatments, which differentiates it through a strong clinical added value in the American biotech sector.
Strengths
- Specialized positioning in genetic oncology diagnostics, a segment with strong growing demand
- Ability to offer diverse and high-value molecular and cytogenetic tests
- Exposure to the American market, the main technological and scientific driver in healthcare
Weaknesses
- Marked volatility in valuation over several years, with a mixed historical performance
- Sensitivity to changes in regulations and reimbursements in the medical sector
Momentum
Recent momentum shows a significant recovery in the medium term despite stability over the year, reflecting a renewed interest from investors in its niche positioning in oncology. This dynamic encourages monitoring of operational developments; however, the recent past necessitates caution regarding the sustainability of the trend.
Similar stocks to Neogenomics
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
